SeXX matters in multiple sclerosis F Gilli, KD DiSano, AR Pachner Frontiers in neurology 11, 616, 2020 | 49 | 2020 |
Intrathecally produced CXCL13: A predictive biomarker in multiple sclerosis KD DiSano, F Gilli, AR Pachner Multiple Sclerosis Journal–Experimental, Translational and Clinical 6 (4 …, 2020 | 45 | 2020 |
Memory B cells in multiple sclerosis: emerging players in disease pathogenesis KD DiSano, F Gilli, AR Pachner Frontiers in Immunology 12, 676686, 2021 | 32 | 2021 |
CXCL13 promotes isotype-switched B cell accumulation to the central nervous system during viral encephalomyelitis TW Phares, KD DiSano, SA Stohlman, BM Segal, CC Bergmann Brain, behavior, and immunity 54, 128-139, 2016 | 28 | 2016 |
IL-21 optimizes T cell and humoral responses in the central nervous system during viral encephalitis TW Phares, KD DiSano, DR Hinton, M Hwang, AJ Zajac, SA Stohlman, ... Journal of neuroimmunology 263 (1-2), 43-54, 2013 | 28 | 2013 |
Central nervous system inflammatory aggregates in the Theiler's virus model of progressive multiple sclerosis KD DiSano, DB Royce, F Gilli, AR Pachner Frontiers in Immunology 10, 1821, 2019 | 26 | 2019 |
Progression From IgD+ IgM+ to Isotype-Switched B Cells Is Site Specific during Coronavirus-Induced Encephalomyelitis TW Phares, KD DiSano, SA Stohlman, CC Bergmann Journal of virology 88 (16), 8853-8867, 2014 | 26 | 2014 |
Differential neuro-immune patterns in two clinically relevant murine models of multiple sclerosis KD DiSano, MR Linzey, DB Royce, AR Pachner, F Gilli Journal of neuroinflammation 16, 1-15, 2019 | 22 | 2019 |
Treatment of Theiler’s virus-induced demyelinating disease with teriflunomide F Gilli, L Li, DB Royce, KD DiSano, AR Pachner Journal of neurovirology 23, 825-838, 2017 | 20 | 2017 |
Activated GL7+ B cells are maintained within the inflamed CNS in the absence of follicle formation during viral encephalomyelitis KD DiSano, SA Stohlman, CC Bergmann Brain, behavior, and immunity 60, 71-83, 2017 | 19 | 2017 |
Clinical utility of a molecular signature in inflammatory demyelinating disease AR Pachner, K DiSano, DB Royce, F Gilli Neurology: Neuroimmunology & Neuroinflammation 6 (1), e520, 2018 | 18 | 2018 |
Are CSF CXCL13 concentrations solely dependent on intrathecal production? A commentary on “Chemokine CXCL13 in serum, CSF, and blood–CSF barrier function” KD DiSano, F Gilli, AR Pachner Fluids and Barriers of the CNS 18, 1-4, 2021 | 7 | 2021 |
Isolating central nervous system tissues and associated meninges for the downstream analysis of immune cells KD DiSano, MR Linzey, NC Welsh, JS Meier, AR Pachner, F Gilli JoVE (Journal of Visualized Experiments), e61166, 2020 | 7 | 2020 |
Divergent complement system activation in two clinically distinct murine models of multiple sclerosis M Linzey, K DiSano, N Welsh, A Pachner, F Gilli Frontiers in Immunology 13, 924734, 2022 | 6 | 2022 |
Pegylated interferon beta in the treatment of the Theiler's murine encephalomyelitis virus mouse model of multiple sclerosis F Gilli, DB Royce, KD DiSano, AR Pachner Journal of neuroimmunology 313, 34-40, 2017 | 5 | 2017 |
An optimized method for enumerating CNS derived memory B cells during viral-induced inflammation KD DiSano, SA Stohlman, CC Bergmann Journal of neuroscience methods 285, 58-68, 2017 | 5 | 2017 |
Quantitative measurement of intrathecally synthesized proteins in mice F Gilli, NC Welsh, MR Linzey, DB Royce, KD DiSano, AR Pachner JoVE (Journal of Visualized Experiments), e60495, 2019 | 2 | 2019 |
High throughput method for detecting murine brain atrophy using a clinical 3T MRI M Linzey, K DiSano, N Welsh, JC Ford, F Gilli, H Wishart, A Pachner BMC Medical Imaging 23 (1), 183, 2023 | 1 | 2023 |
Sexually dimorphic intrathecal inflammation in a murine model of progressive MS N Welsh, K DiSano, M Linzey, A Pachner, F Gilli MULTIPLE SCLEROSIS JOURNAL 26 (1_ SUPPL), 78-79, 2020 | 1 | 2020 |
Elevated Cerebrospinal Fluid CXCL13 Helps Predict Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody Associated Disorders (MOGAD)(P9-14.016) N Karbhari, A Pachner, F Gilli, K DiSano, A Smith, N Robbins Neurology 102 (17_supplement_1), 6000, 2024 | | 2024 |